Netherlands· NL-530839a6a21c
Ceprotin 500 IE, poeder en oplosmiddel voor oplossing voor injectie
A protein c product containing proteïne c, humaan, registered in Netherlands by Baxter AG (Industriestrasse 67). The same ATC class is registered in 9 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Protein c is registered in 9 of 19 countries.
Countries holding a registration under ATC B01AD12 (protein c), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Protein c · ATC B01AD12
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- PROTEÏNE C, HUMAAN
- Manufacturer
- Baxter AG (Industriestrasse 67)
- Country
- Netherlands (NL)
- ATC code
- B01AD12
- ATC class
- Protein C
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/01/190
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
34 interactions on record for protein c.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Protein c · interactions on record
34 records
- 1 severe
- 33 moderate
Most severe, free to view
- CaplacizumabB01AX07severe
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- HeparinB01AB01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B01AD12
Protein c, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cfd279e3-f012-4892-a16b-456af95c0655 GET /v1/drugs/cfd279e3-f012-4892-a16b-456af95c0655?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder en oplosmiddel voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ceprotin-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Protein C",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70917",
"excipients": [
"HUMAAN ALBUMINE",
"NATRIUMCHLORIDE",
"TRINATRIUMCITRAAT 2-WATER (E 331)",
"WATER VOOR INJECTIE"
],
"substances": [
"PROTEÏNE C, HUMAAN"
],
"leaflet_url": null,
"authorised_at": "2001/07/16",
"procedure_number": "EMEA/H/C/000334",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/01/190",
"additional_monitoring": "N"
}See everything about protein c.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.